{"id": "1345316439570477057", "creation": 1609583408.0, "user_id": "2467319924", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 2, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "First interim #data from Phase 3 study of the Sputnik V #vaccine demonstrates 92 percent #efficacy, with no unexpected adverse events occurring during the #clinical #trial.\n#COVID19 #research #clinicaltrial\n\nhttps://t.co/hd62YFi9vg https://t.co/K66yirIrUu", "first_save": 1634559108.199414, "hashtags": ["#DATA", "#VACCINE", "#EFFICACY", "#CLINICAL", "#TRIAL", "#COVID19", "#RESEARCH", "#CLINICALTRIAL"]}